Bronchodilator Tablet Franchise in Ahmedabad

Theoclin 600 Tablet Supplier in Mumbai

Theophylline Tablet Distributor in Delhi

Respiratory Care Tablet Manufacturer in Bangalore

Asthma & COPD Tablet Stockist in Hyderabad
Bronchodilator Tablet Exporter in Chandigarh

Home/Products /theophylline-600mg-tablet

Theoclin 600 Tablet

Composition : Theophylline (600mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Theoclin 600 Tablet contains Theophylline 600mg, a well-known methylxanthine bronchodilator used in the management of chronic respiratory disorders. It helps in relaxing bronchial smooth muscles, thereby improving airflow and easing breathing difficulties in patients with obstructive airway diseases.

Theophylline works by inhibiting phosphodiesterase enzymes and blocking adenosine receptors, leading to bronchodilation and reduced airway responsiveness. It also improves diaphragmatic contractility and respiratory muscle function, contributing to better ventilation.

Clinically, Theoclin 600 Tablet is indicated for bronchial asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, and emphysema. The sustained therapeutic effect of the tablet helps in maintaining airway patency and reducing the frequency of bronchospasm episodes when used as prescribed.

Regular use under medical supervision supports improved lung function, reduced breathlessness, and enhanced exercise tolerance. Theoclin 600 Tablet remains a trusted option in long-term respiratory management, offering effective bronchodilation and consistent symptom control.

Read More

About the Product

Theoclin 600 Tablet contains Theophylline 600mg, a well-known methylxanthine bronchodilator used in the management of chronic respiratory disorders. It helps in relaxing bronchial smooth muscles, thereby improving airflow and easing breathing difficulties in patients with obstructive airway diseases.

Theophylline works by inhibiting phosphodiesterase enzymes and blocking adenosine receptors, leading to bronchodilation and reduced airway responsiveness. It also improves diaphragmatic contractility and respiratory muscle function, contributing to better ventilation.

Clinically, Theoclin 600 Tablet is indicated for bronchial asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, and emphysema. The sustained therapeutic effect of the tablet helps in maintaining airway patency and reducing the frequency of bronchospasm episodes when used as prescribed.

Regular use under medical supervision supports improved lung function, reduced breathlessness, and enhanced exercise tolerance. Theoclin 600 Tablet remains a trusted option in long-term respiratory management, offering effective bronchodilation and consistent symptom control.

Common side effects may include nausea, vomiting, headache, insomnia, or mild stomach upset. Rarely, palpitations, tremors, or serious cardiac and central nervous system effects may occur, especially with high doses or prolonged use.

Theoclin 600 Tablet is indicated for the management of bronchial asthma, chronic obstructive pulmonary disease (COPD), and other conditions associated with reversible airway obstruction, as advised by a physician.

For oral use only. Use strictly under medical supervision. Do not exceed the prescribed dose. Therapeutic drug monitoring may be required during long-term therapy. Inform your doctor if you have heart disease, liver disorders, or are taking other medications that may interact with Theophylline.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep the tablets in a tightly closed container and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation